OpenVSafe by OpenVAERS
Search V-safe

AYK-33815-60204

2 vaccinations 12 coded responses 19 check-ins 12 free-text entries 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
010 / MA
Registered
2020-12-23
Relationship
Self
Race
N/A
Ethnicity
N/A

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-23
    Survey response — day 0, dose 1
    MedDRA: Immediate post-injection reaction, Pruritus — Feeling: Fair · Site: Pain · Headache
    Free text: Brief itching of hands a few minutes after vaccination, resolved after a few minutes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain · Headache
    Free text: I don't think this is related, as I worked a night shift and always have this afterward
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  7. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains
    Adult check-in
  8. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-08
    Survey response — day 14, dose 1
    MedDRA: Headache — Feeling: Poor · Be unable to do your normal daily activities
    Free text: I have a headache today. It could be due to working a night shift.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-08
    Report sent to call center — day 14, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  11. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-13
    Survey response — day 0, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: I just got it 5 minutes ago
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: SARS-CoV-2 test — Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Required covid test to be cleared to return to work. Drive up test.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain — Feeling: Fair · Fever · Headache, Fatigue or tiredness
    Free text: Tender axillary lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness, Nausea
    Adult check-in
  17. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-27
    Survey response — day 14, dose 2
    MedDRA: Nausea — Feeling: Fair
    Free text: Nausea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-05
    Survey response — day 21, dose 2
    MedDRA: Asthenia, Myalgia — Feeling: Fair
    Free text: Muscle aches and weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-12
    Survey response — day 28, dose 2
    MedDRA: Chest pain — Feeling: Poor
    Free text: Chest pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-26
    Survey response — day 42, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Ongoing axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-05
  23. 2021-03-11
  24. 2021-03-16
  25. 2021-04-14
    Survey response — 3 months, dose 2
    MedDRA: Chest pain, Heart rate increased — Feeling: Fair
    Free text: I had exertional chest pain during a couple workouts and higher heart rates during workouts for a couple weeks afterwards
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-07-14
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-01-15
    Survey response — 12 months, dose 2
    MedDRA: Abdominal pain, Brain fog, Lymphadenopathy, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Abdominal pain Lymphadenopathy Brain fog I had a cold and tested negative for covid 19
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-13Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-23

Systemic reaction (other): Brief itching of hands a few minutes after vaccination, resolved after a few minutes

Release 1 — days 1–6 daily, dose 1

2020-12-24

Systemic reaction (other): I don't think this is related, as I worked a night shift and always have this afterward

Release 1 — day 14, dose 1

2021-01-08

Symptoms: I have a headache today. It could be due to working a night shift.

Release 1 — day 0, dose 2

2021-01-13

Systemic reaction (other): I just got it 5 minutes ago

Release 2 — days 1–6 daily, dose 2

2021-01-14

Healthcare visit (other): Required covid test to be cleared to return to work. Drive up test.

2021-01-15

Systemic reaction (other): Tender axillary lymph nodes

Release 2 — day 14, dose 2

2021-01-27

Symptoms: Nausea

Release 3 — day 21, dose 2

2021-02-05

Symptoms: Muscle aches and weakness

Release 4 — day 28, dose 2

2021-02-12

Symptoms: Chest pain

Release 4 — day 42, dose 2

2021-02-26

Symptoms: Ongoing axillary lymphadenopathy

Release 7 — 3 months, dose 2

2021-04-14

Symptoms: I had exertional chest pain during a couple workouts and higher heart rates during workouts for a couple weeks afterwards

Release 10 — 12 months, dose 2

2022-01-15

Symptoms: Abdominal pain Lymphadenopathy Brain fog I had a cold and tested negative for covid 19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOSARS-CoV-2 test ✓ ✓ ✓
SDAbdominal pain · · ✓
SDAsthenia ✓ ✓ ✓
SDBrain fog · · ✓
SDChest pain ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHeart rate increased ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDNausea ✓ ✓ ✓
SDSARS-CoV-2 test negative · · ✓
SROImmediate post-injection reaction ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROPruritus ✓ ✓ ✓
SROUnevaluable event ○ ○ ○

✓ active code · ○ coded but marked inactive · blank = not in that release